US › Healthcare

MapLight Therapeutics, Inc. Common Stock (MPLT)

US · Healthcare · Biotechnology

$11.32-0.70%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-60.2M

EPS

$-1.32

EPS estimate

$-1.40

EPS came in at -1.32 against a street estimate of -1.40 — a beat of 5.7%.

Key statistics

Market cap

$602.9M

Forward P/E

0.0

P/B

1.85

Book value

$7.67

EPS (TTM)

$-18.72

52-week high

$40.43

52-week low

$9.10

50-day MA

$20.89

200-day MA

$21.96

Analyst view

with an average price target of $26.54.

Shareholding

Insiders

63.33%

Institutions

58.87%

Largest institutional holders

Fund	Stake
Novo A/S	7.95%
FCPM III SERVICES BV	6.96%
T. Rowe Price Investment Management,Inc.	6.04%
The Goldman Sachs Group Inc	4.30%
BlackRock Inc	2.89%
Nan Fung Group Holdings Ltd	2.09%
5AM Venture Management, LLC	2.05%
Sanofi	1.97%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for MapLight Therapeutics, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.